运动神经元疾病可以呈现为具有各种表型的瘤神经系统综合征
Eleftheria Koropouli1, Stavros Bellos1, Stavroula Aristeidou1
1First Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens School of Medicine, Vasilissis Sofias Avenue 72-74, Athens 11528, Greece.
Brain communications
|March 10, 2026
概括
麻性运动神经元疾病 (PNMD) 是一种罕见的与癌症相关的神经系统疾病. 这项研究证实PNMD的存在,提出了四个新的病例和一个元分析,突出了其多样化的表现和与特定抗体的关联.
科学领域:
- 神经学 神经学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 麻性运动神经元疾病 (PNMD) 是一种罕见的神经系统综合征,存在含糊不清.
- 相互矛盾的流行病学研究和有限的病例报告需要对PNMD进行进一步的调查.
- 来自案例研究的证据表明癌症和运动神经元疾病之间存在联系,但缺乏确的数据.
研究的目的:
- 为了证实对瘤性运动神经元疾病 (PNMD) 的存在.
- 描述PNMD的临床和实验室概况.
- 调查PNMD,瘤性疾病和脑神经抗体之间的关联.
主要方法:
- 报告了四例新发的副发性运动神经元疾病 (PNMD).
- 对所有符合纳入标准的PNMD病例进行了系统审查.
- 进行了对人口统计,临床和实验室特征的个人参与者数据元分析.
主要成果:
- 证实,运动神经元疾病可以表现为神经瘤神经综合征.
- PNMD存在于整个运动神经元疾病谱中,与各种癌症和神经元抗体有关.
- 独特的临床特征是快速进展;在一些病例的子集中观察到CSF的免疫失调.
结论:
- 副发性运动神经元疾病 (PNMD) 是一个独特的实体,除了其快速进展外,通常在临床上与异常运动神经元疾病无法区分.
- 癌症引起的炎症可能会在基因敏感的个体中引发PNMD.
- 对于疑似PNMD病例来说,彻底的癌症评估至关重要,这可能会揭示对异常运动神经元疾病病原体的洞察力.
相关概念视频
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Pleiotropy
43.8K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.8K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K


